A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

NCT06429137 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2025-06-11

No results posted yet for this study

Summary

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3731579 in healthy male subjects.

Conditions

  • Healthy

Interventions

DRUG

BI 3731579

BI 3731579

DRUG

Matching placebo to BI 3731579

Matching placebo to BI 3731579

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-08
Primary Completion
2025-05-19
Completion
2025-05-27

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06429137 on ClinicalTrials.gov